Fintel reports that on February 14, 2025, Wells Fargo initiated coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 21.64% Upside As of ...

Al Roker is back on Today two days after the death of his ex-wife, Alice Bell. After his absence from Today on the Tuesday, ...

The San Francisco-based bank announced that another consent order with the Office of the Comptroller of the Currency has been ...

The Dow Jones Industrial Average shed 165.35 points, or 0.37%, closing at 44,546.08. The S&P 500 ticked down 0.01% to ...

Visa is preparing to offer account-to-account (A2A) payment services in 2025. The company plans to rollout its A2A platform ...

DaVita shares tumbled after issuing a weak outlook amid rising care costs, while big investor Berkshire offloaded some shares ...

Wells Fargo (NYSE:WFC) began coverage on DENTSPLY SIRONA (NASDAQ: NASDAQ:XRAY) shares, assigning an Equal Weight rating and setting a price target of $20.00. The new rating comes as DENTSPLY SIRONA's ...

Many or all of the products on this page are from partners who compensate us when you click to or take an action on their website, but this does not influence our evaluations or ratings. Our ...

JMP Securities reaffirmed their market outperform rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a report released on Tuesday,Benzinga reports. JMP Securities currently has ...

It marks another quarter of growing pains for the company, which is racing to launch new products and recover from the ...

Shares of Pliant Therapeutics, Inc. (NASDAQ:PLRX – Get Free Report) have been given an average rating of “Hold” by the eleven analysts that are presently covering the company, Marketbeat reports.